Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Immunization with 1976 swine H1N1- or 2009 pandemic H1N1-inactivated vaccines protects mice from a lethal 1918 influenza infection.

Easterbrook JD, Kash JC, Sheng ZM, Qi L, Gao J, Kilbourne ED, Eichelberger MC, Taubenberger JK.

Influenza Other Respir Viruses. 2011 May;5(3):198-205. doi: 10.1111/j.1750-2659.2010.00191.x. Epub 2011 Jan 25.

2.

Cold-adapted influenza and recombinant adenovirus vaccines induce cross-protective immunity against pH1N1 challenge in mice.

Soboleski MR, Gabbard JD, Price GE, Misplon JA, Lo CY, Perez DR, Ye J, Tompkins SM, Epstein SL.

PLoS One. 2011;6(7):e21937. doi: 10.1371/journal.pone.0021937. Epub 2011 Jul 15.

3.

Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: the role of viral membrane fusion activity.

Budimir N, Huckriede A, Meijerhof T, Boon L, Gostick E, Price DA, Wilschut J, de Haan A.

PLoS One. 2012;7(1):e30898. doi: 10.1371/journal.pone.0030898. Epub 2012 Jan 27.

4.

Modified vaccinia virus Ankara expressing the hemagglutinin of pandemic (H1N1) 2009 virus induces cross-protective immunity against Eurasian 'avian-like' H1N1 swine viruses in mice.

Castrucci MR, Facchini M, Di Mario G, Garulli B, Sciaraffia E, Meola M, Fabiani C, De Marco MA, Cordioli P, Siccardi A, Kawaoka Y, Donatelli I.

Influenza Other Respir Viruses. 2014 May;8(3):367-75. doi: 10.1111/irv.12221. Epub 2013 Dec 23.

5.

Protection of mice against lethal challenge with 2009 H1N1 influenza A virus by 1918-like and classical swine H1N1 based vaccines.

Manicassamy B, Medina RA, Hai R, Tsibane T, Stertz S, Nistal-Villán E, Palese P, Basler CF, García-Sastre A.

PLoS Pathog. 2010 Jan 29;6(1):e1000745. doi: 10.1371/journal.ppat.1000745.

6.

An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus.

Zhao G, Sun S, Du L, Xiao W, Ru Z, Kou Z, Guo Y, Yu H, Jiang S, Lone Y, Zheng BJ, Zhou Y.

Virol J. 2010 Jul 12;7:151. doi: 10.1186/1743-422X-7-151.

7.

Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.

Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC.

J Virol. 2015 Jul;89(14):7224-34. doi: 10.1128/JVI.00585-15. Epub 2015 May 6.

8.

Cross-protection by co-immunization with influenza hemagglutinin DNA and inactivated virus vaccine using coated microneedles.

Kim YC, Yoo DG, Compans RW, Kang SM, Prausnitz MR.

J Control Release. 2013 Dec 10;172(2):579-88. doi: 10.1016/j.jconrel.2013.04.016. Epub 2013 Apr 30.

9.

Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.

Wen F, Yu H, Yang FR, Huang M, Yang S, Zhou YJ, Li ZJ, Tong GZ.

Arch Virol. 2014 Nov;159(11):2957-67. doi: 10.1007/s00705-014-2151-y. Epub 2014 Jun 24.

PMID:
24957653
10.

A contributing role for anti-neuraminidase antibodies on immunity to pandemic H1N1 2009 influenza A virus.

Marcelin G, DuBois R, Rubrum A, Russell CJ, McElhaney JE, Webby RJ.

PLoS One. 2011;6(10):e26335. doi: 10.1371/journal.pone.0026335. Epub 2011 Oct 24.

11.

Evaluation of the efficacy and cross-protectivity of recent human and swine vaccines against the pandemic (H1N1) 2009 virus infection.

Pascua PN, Song MS, Lee JH, Park KJ, Kwon HI, Baek YH, Hong SP, Rho JB, Kim CJ, Poo H, Ryoo TS, Sung MH, Choi YK.

PLoS One. 2009 Dec 23;4(12):e8431. doi: 10.1371/journal.pone.0008431.

12.
13.

Modifications in the polymerase genes of a swine-like triple-reassortant influenza virus to generate live attenuated vaccines against 2009 pandemic H1N1 viruses.

Pena L, Vincent AL, Ye J, Ciacci-Zanella JR, Angel M, Lorusso A, Gauger PC, Janke BH, Loving CL, Perez DR.

J Virol. 2011 Jan;85(1):456-69. doi: 10.1128/JVI.01503-10. Epub 2010 Oct 20.

14.

Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.

Du N, Li W, Li Y, Liu S, Sui Y, Qu Z, Wang Y, Du Y, Xu B.

Vaccine. 2008 Jun 2;26(23):2912-8. doi: 10.1016/j.vaccine.2008.03.048. Epub 2008 Apr 11.

PMID:
18448208
15.

Revisiting the 1976 "swine flu" vaccine clinical trials: cross-reactive hemagglutinin and neuraminidase antibodies and their role in protection against the 2009 H1N1 pandemic virus in mice.

Xie H, Li X, Gao J, Lin Z, Jing X, Plant E, Zoueva O, Eichelberger MC, Ye Z.

Clin Infect Dis. 2011 Dec;53(12):1179-87. doi: 10.1093/cid/cir693. Epub 2011 Oct 5.

16.

Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.

Tsukamoto M, Hiroi S, Adachi K, Kato H, Inai M, Konishi I, Tanaka M, Yamamoto R, Sawa M, Handharyani E, Tsukamoto Y.

Mol Med Rep. 2011 Mar-Apr;4(2):209-14. doi: 10.3892/mmr.2011.410. Epub 2011 Jan 3.

PMID:
21468553
17.

Experimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virus.

Busquets N, Segalés J, Córdoba L, Mussá T, Crisci E, Martín-Valls GE, Simon-Grifé M, Pérez-Simó M, Pérez-Maíllo M, Núñez JI, Abad FX, Fraile L, Pina S, Majó N, Bensaid A, Domingo M, Montoya M.

Vet Res. 2010 Sep-Oct;41(5):74. doi: 10.1051/vetres/2010046. Epub 2010 Jul 29.

18.

Seasonal influenza infection and live vaccine prime for a response to the 2009 pandemic H1N1 vaccine.

Chen GL, Lau YF, Lamirande EW, McCall AW, Subbarao K.

Proc Natl Acad Sci U S A. 2011 Jan 18;108(3):1140-5. doi: 10.1073/pnas.1009908108. Epub 2011 Jan 3.

19.

A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizations.

Hessel A, Schwendinger M, Fritz D, Coulibaly S, Holzer GW, Sabarth N, Kistner O, Wodal W, Kerschbaum A, Savidis-Dacho H, Crowe BA, Kreil TR, Barrett PN, Falkner FG.

PLoS One. 2010 Aug 16;5(8):e12217. doi: 10.1371/journal.pone.0012217.

20.

A whole virus pandemic influenza H1N1 vaccine is highly immunogenic and protective in active immunization and passive protection mouse models.

Kistner O, Crowe BA, Wodal W, Kerschbaum A, Savidis-Dacho H, Sabarth N, Falkner FG, Mayerhofer I, Mundt W, Reiter M, Grillberger L, Tauer C, Graninger M, Sachslehner A, Schwendinger M, Brühl P, Kreil TR, Ehrlich HJ, Barrett PN.

PLoS One. 2010 Feb 23;5(2):e9349. doi: 10.1371/journal.pone.0009349.

Items per page

Supplemental Content

Write to the Help Desk